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Xenotropic murine leukemia virus-related virus (XMRV)
has been found in a high percentage of humans with
chronic fatigue syndrome (CFS). However, more recent
studies have failed to confirm these results, and it now
appears likely that the original findings were due to
patient sample contamination. Because it initially
appeared that XMRV was involved in CFS, we explored
potential mechanisms of XMRV neurotoxicity that
might underliethe neuromuscular pathology seen in
CFS. Indeed, we found that XMRV infection induced
apoptosis in SY5Y human neuroblastoma cells. We
hypothesized that signaling through the cell-entry recep-
tor for XMRV, the xenotropic and polytropic retrovirus
receptor (Xpr1), mediated this toxicity. In support of
this hypothesis, SY5Y cells expressing mouse Xpr1,
which unlike human Xpr1 does not bind or promote
entry of xenotropic retroviruses, were resistant to
XMRV toxicity, even though XMRV could still infect
these cells. Similarly, SY5Y cells expressing several
XMRV binding-defective deletion mutants of human
Xpr1 were resistant to XMRV toxicity. These results
indicate that Xpr1 mediates the toxicity of XMRV.
Xpr1 is related the yeast Syg1 protein, which associ-
ates with the b subunit of the yeast G-protein. We
found that human Xpr1 is also associated with the
human Gb s u b u n i t ,a n dt h a to v e re x p r e s s i o no fm o u s e
or human Xpr1 increased intracellular cAMP, a typical
output of stimulatory G-protein signaling. Moreover,
increasing the cAMP level in SY5Y cells by direct activa-
tion of adenylate cyclase protected the SY5Y cells from
the toxic effects of XMRV and polytropic retrovirus
infection. These results indicate that Xpr1 is a G-pro-
tein-coupled receptor (GPCR), and that xenotropic or
polytropic retrovirus binding can disrupt the cAMP-
mediated signaling function of Xpr1 leading to apoptosis
of infected cells. In addition, we found that this pathway
is responsible for the toxicity of the polytropic mink cell
focus-forming (MCF) retrovirus in mink cells, the basis
for the classic MCF focus assay.Xpr1 orthologs are
widely distributed in animals, plants and unicellular
organisms, but these proteins show no sequence similar-
ity to known GPCRs. Some proteins with similarity to
Xpr1 are involved in phosphate uptake into cells, but we
found no role of Xpr1 in phosphate uptake or its regula-
tion. Lastly, some polytropic retroviruses induce neuro-
logic disease in mice, and we propose that alterations of
Xpr1-mediated G-protein signalinglikely are responsible.
However, because of recent results indicting that XMRV
is not a human retrovirus, a role for XMRV in human
disease is unlikely.
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